PRESS RELEASE published on 08/28/2023 at 13:30, 2 years 11 months ago NLS Pharmaceutics CEO Issues Letter to Shareholders
PRESS RELEASE published on 05/02/2023 at 14:45, 3 years 3 months ago NLS Pharmaceutics Receives Green Light from the U.S. FDA to Proceed with Phase 3 Clinical Program (AMAZE) for Quilience(R) (Mazindol ER) for the Treatment of Narcolepsy
PRESS RELEASE published on 03/27/2023 at 14:30, 3 years 4 months ago NLS Pharmaceutics Announces Open Label Extension Study Six-Month Data for Quilience(R) (Mazindol ER) in the Treatment of Narcolepsy Type 1 and Type 2
PRESS RELEASE published on 01/23/2023 at 14:30, 3 years 6 months ago NLS Pharmaceutics Announces New In-Vitro Data Reconfirming Quilience's(R) (Mazindol ER) Unique Dual Mechanism of Action Involving Significant Orexin-2 Receptor Activity
PRESS RELEASE published on 01/12/2023 at 14:30, 3 years 6 months ago NLS Pharmaceutics Announces an R&D Update Webcast to Review the Company's Growing Portfolio of Pre-Clinical Compounds
Published on 08/04/2026 at 09:10, 1 hour 49 minutes ago HM Exploration Drills 18.45 Metres of 1.14% Cu, 2.42 % Zn, 16.74 g/t Ag and 0.32 g/t Au in Upper Lens; 5.42m of 1.99% Cu, 1.66% Zn, 15.39g/t Ag and 0.8g/t Au in Lower lens at Lewis Pilley's
Published on 08/04/2026 at 09:05, 1 hour 54 minutes ago BioNxt Provides Development, Intellectual Property and Commercial Update Across Sublingual Drug Delivery Pipeline
Published on 08/03/2026 at 23:00, 11 hours 59 minutes ago Viemed Healthcare Announces Second Quarter 2026 Financial Results
Published on 08/01/2026 at 01:58, 3 days 9 hours ago Clôture de l'option sur la propriété de graphite au Québec
Published on 08/01/2026 at 01:20, 3 days 9 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/04/2026 at 10:43, 16 minutes ago coinIX invests in Ampli - Infrastructure for AI-based asset management
Published on 08/04/2026 at 10:34, 25 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3H and Appendix 3Y
Published on 08/04/2026 at 10:15, 44 minutes ago A Decade Beyond Boundaries: AKKO Celebrates 10th Anniversary with New European Products and IFA 2026 Showcase
Published on 08/04/2026 at 10:11, 48 minutes ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Published on 08/04/2026 at 10:11, 48 minutes ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Published on 08/04/2026 at 08:15, 2 hours 44 minutes ago Covivio - Modalités de mise à disposition du Rapport Financier Semestriel 2026
Published on 08/04/2026 at 08:15, 2 hours 44 minutes ago Covivio - Conditions of availability of the 2026 Half-year report
Published on 08/03/2026 at 18:45, 16 hours 14 minutes ago Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 08/03/2026 at 18:45, 16 hours 14 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 08/03/2026 at 18:35, 16 hours 24 minutes ago Covivio Hotels - Informations relatives au nombre total de droits de vote et d'actions composant le capital social
